首页> 外文期刊>Medical oncology >Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer
【24h】

Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer

机译:miR-223的过表达与大肠癌患者的肿瘤转移和预后不良有关

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the study was to investigate microRNA-223 (miR-223) expression in colorectal cancer (CRC) and its relationship with tumorigenesis and disease prognosis. Quantitative real-time PCR was used to measure levels of miR-223 in tumor samples and adjacent non-cancerous tissues from 62 patients undergoing radical resection for the treatment of CRC. The associations between miR-223 expression and patient age, sex, as well as clinicopathologic parameters, such as tumor size, differentiation, location, invasion depth, metastasis, tumornode- metastasis (TNM) stage, and overall patient survival, were analyzed by Mann-Whitney U and Kruskal-Wallis tests. Kaplan-Meier method and Cox proportional hazards regression analyses were performed to estimate the prognostic factors for patient survival prediction. The expression of miR-223 was significantly upregulated in CRC tissues compared with adjacent non-cancerous tissues (P<0.05). This overexpression was associated with TNM stage and lymph node and distant metastases, (P<0.05). Moreover, Kaplan-Meier analysis demonstrated that patients with high miR-223 expression had a poorer overall survival (OS) than those with low miR-223 expression (P = 0.002). Univariate analysis revealed a statistically significant correlation between OS and miR-223 level, histology grade, metastasis and TNM stage (P<0.001). Furthermore, miR-223 levels and histology grade were independently associated with OS (HR 0.204, 95 % CI 0.101-0.415, P<0.05 and HR 2.252, 95 % CI 1.429-3.546, P<0.05, respectively). The overexpression of miR-223 may play an important role in the progression of CRC and can be used as an independent factor to determine CRC prognosis.
机译:该研究的目的是研究大肠癌(CRC)中的microRNA-223(miR-223)表达及其与肿瘤发生和疾病预后的关系。实时荧光定量PCR用于测量62例接受根治性切除术治疗CRC的患者的肿瘤样品和邻近非癌组织中的miR-223水平。通过Mann分析了miR-223表达与患者年龄,性别以及临床病理参数(例如肿瘤大小,分化,位置,浸润深度,转移,肿瘤淋巴结转移(TNM)阶段)和患者总体生存率之间的关联。 -Whitney U和Kruskal-Wallis测试。进行了Kaplan-Meier方法和Cox比例风险回归分析,以评估患者生存预测的预后因素。与邻近的非癌组织相比,miR-223在CRC组织中的表达明显上调(P <0.05)。该过表达与TNM分期和淋巴结转移及远处转移有关(P <0.05)。此外,Kaplan-Meier分析表明,与低miR-223表达的患者相比,高miR-223表达的患者的总生存期(OS)较差(P = 0.002)。单因素分析显示OS与miR-223水平,组织学分级,转移和TNM分期之间存在统计学上的显着相关性(P <0.001)。此外,miR-223水平和组织学分级与OS独立相关(HR 0.204,95%CI 0.101-0.415,P <0.05; HR 2.252,95%CI 1.429-3.546,P <0.05)。 miR-223的过表达可能在CRC的进展中起重要作用,并且可以用作确定CRC预后的独立因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号